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ABSTRACT
Objectives: Postnatal maternal mental health
problems, including depression and anxiety, entail a
significant burden globally, and finding cost-effective
preventive solutions is a public policy priority. This
paper presents a cost-effectiveness analysis of the
intervention, What Were We Thinking (WWWT), for the
prevention of postnatal maternal mental health
problems.
Design: The economic evaluation, including cost-
effectiveness and cost-utility analyses, was conducted
alongside a cluster-randomised trial.
Setting: 48 Maternal and Child Health Centres in
Victoria, Australia.
Participants: Participants were English-speaking first-
time mothers attending participating Maternal and
Child Health Centres. Full data were collected for 175
participants in the control arm and 184 in the
intervention arm.
Intervention: WWWT is a psychoeducational
intervention targeted at the partner relationship,
management of infant behaviour and parental fatigue.
Outcome measures: The evaluation considered
public sector plus participant out-of-pocket costs, while
outcomes were expressed in the 30-day prevalence of
depression, anxiety and adjustment disorders, and
quality-adjusted life years (QALYs). Incremental costs
and outcomes were estimated using regression
analyses to account for relevant sociodemographic,
prognostic and clinical characteristics.
Results: The intervention was estimated to cost
$A118.16 per participant. The analysis showed no
statistically significant difference between the
intervention and control groups in costs or outcomes.
The incremental cost-effectiveness ratios were
$A36 451 per QALY gained and $A152 per percentage-
point reduction in 30-day prevalence of depression,
anxiety and adjustment disorders. The estimate lies
under the unofficial cost-effectiveness threshold of
$A55 000 per QALY; however, there was considerable
uncertainty surrounding the results, with a 55%
probability that WWWT would be considered cost-
effective at that threshold.
Conclusions: The results suggest that, although
WWWT shows promise as a preventive intervention for
postnatal maternal mental health problems, further
research is required to reduce the uncertainty over its
cost-effectiveness as there were no statistically
significant differences in costs or outcomes.
Trial registration number: ACTRN12613000506796;
results.
BACKGROUND
Prevention of postnatal mental health pro-
blems is a challenge for healthcare systems
internationally. Depression, anxiety and
adjustment disorders are common among
women who have recently given birth1 2
which is a population subgroup of substantial
size. These disorders have a signiﬁcant
impact on the well-being of women at a
pivotal time in the life of the mother, baby
Strengths and limitations of this study
▪ The prospectively designed economic evaluation
was conducted alongside a cluster-randomised
controlled trial of the intervention’s clinical
effectiveness.
▪ The sample size, based on the clinical effect
rather than cost-effectiveness analysis, and the
cluster-randomised nature of the trial may have
limited the ability to detect statistically significant
differences between the control and intervention
groups.
▪ Data collected in the trial included use of health,
social and early childhood services and partici-
pant out-of-pocket costs, allowing the results to
be examined from a range of perspectives.
▪ Results presented include probabilistic sensitivity
analysis and scenario analyses to allow the
reader to assess the impact of key uncertainties.
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and wider family.3 4 There is an associated burden on
the public sector; for example, women with postnatal
depression (PND) have higher use of health and other
services than their non-depressed counterparts, not
limited to greater use of mental health services.5–7
Research on the cost-effectiveness of interventions to
prevent the development of postnatal distress, depres-
sion and anxiety has shown mixed results. A programme
of structured midwife-led care was found to improve
postnatal mental health without increasing costs;8 coun-
selling and support for women at high risk of PND9 and
peer support10 were found to reduce symptoms or dur-
ation of depression but at a higher cost; and postnatal
support worker home visits11 were found to increase
costs with no associated improvement in mental health.
Preventive approaches that address the woman’s relation-
ship with her spouse or partner have shown some
promise in terms of clinical effectiveness;12 however,
there has been little research into the cost-effectiveness
of such interventions.
What Were We Thinking (WWWT) is a psychoeducational
intervention that targets the parental partner relation-
ship, management of infant behaviour and parental
fatigue. A community-based before and after controlled
study found that WWWT reduced postnatal mental
health problems among women with no history of psy-
chiatric disorders.13 The Sleep, Parenting and
Relationships in a Community Setting (SPARCS) trial
was subsequently conducted to examine the clinical and
cost-effectiveness of WWWT for the prevention of depres-
sion, anxiety and adjustment disorders in women at
6 months postpartum.14 The intervention was delivered
soon after birth to ﬁrst-time parents (FTPs) in the
setting of Maternal and Child Health Centres (MCHCs)
in Victoria, Australia. MCHCs are a publicly funded uni-
versal service for families of children up to school age,
with the goal to ‘promote healthy outcomes for children
and their families’ (ref. 15, p. 6). High participation
rates are a stated policy objective in pursuance of this
goal; more than 90% of families with recent births in
Victoria attend MCHCs.16 One element of the Maternal
and Child Health (MCH) service is FTP group sessions,
which focus on parent–child interactions, parenting con-
ﬁdence, emotional well-being and support for FTPs.17
Public sector decision-makers have made a commit-
ment to using evidence to inform modiﬁcations to the
MCH service model.18 A complexity of developing appro-
priate evidence is that in Victoria, early childhood service
costs (including MCHCs) fall under the Department of
Education and Training (formerly the Department of
Education and Early Childhood Development). This
means that funding of MCHCs is shared between the
Department of Education and Training and Local
Governments, rather than sitting within health, despite
the clear health focus of the MCH service.
Economic evaluation provides decision-makers with
evidence on how best to allocate limited resources by
comparing the alternatives in terms of costs and
outcomes. In cost-effectiveness analyses (CEA), out-
comes are expressed in natural or clinical units, such as
symptom improvement or life years saved. In cost-utility
analyses (CUA), outcomes are expressed in terms of
quality-adjusted life years (QALYs), which take into
account differences in life span and health-related
quality of life (HRQoL). QALYs are generally preferred
in health economic evaluations as they facilitate alloca-
tive decisions between interventions with different out-
comes,19 20 and there are data to guide what might be
considered cost-effective in terms of QALYs. However,
studies in prevention of postnatal mental health pro-
blems often use condition-speciﬁc clinical end points,
such as cost per month of PND averted.9 It is not clear
what societies would be willing to pay for prevention in
terms of these clinical end points. One US study found
individuals were willing to pay ∼9% of their monthly
household income for treatment of depression,21 and a
German study found that people were willing to pay per-
sonally for prevention of depression;22 however, neither
informs us of societal-level willingness-to-pay (WTP) for
prevention of depression. Although not an ofﬁcial
threshold, US$50 000 per QALY (approximately
$A55 000 in 2014) is often used as a guide, which could
vary with factors such as budget constraints or special
consideration of certain populations or diseases.23 Other
thresholds have been proposed, and vary considerably;24
one study found that Australian WTP for one QALY gain
was approximately $A75 000,25 while in the UK, a thresh-
old of £20 000–30 000 (approximately $A41 000–61 000)
per QALY gained is used,26 although Claxton et al27
suggest it should be lower, approximately $A31 000
(ﬁgures adjusted to 2014 terms).
This paper describes the results of an economic evalu-
ation of WWWT conducted alongside the SPARCS trial.
The protocols for the clinical study14 and economic
evaluation28 have been published previously, as have the
trial results.29 This paper presents the results of a CEA
and a CUA, and discusses the implications of these
results for decision-makers seeking cost-effective inter-
ventions for the prevention of postnatal mental health
problems.
METHODS
The economic evaluation took a public sector perspec-
tive (incorporating healthcare, early childhood and
social service costs), plus the participant’s out-of-pocket
(OOP) costs. The time horizon of 6 months mirrored
the trial follow-up period. No discounting was necessary
due to the duration of the follow-up period. Ethical
approval was provided by the Southern Health (now
Monash Health) Human Research Ethics Committee
(11388B) and the Education and Policy Research
Committee, Victorian Government Department of
Education and Early Childhood Development (now
Department of Education and Training) (2012 001472),
and the study was registered with the Monash University
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Human Research Ethics Committee (CF12/
1022-20122000474). Data were collected from partici-
pants via computer-assisted telephone interview at base-
line (6 weeks postpartum) and follow-up (26 weeks
postpartum).
Sample and setting
The trial was conducted in Victoria, Australia, with
MCHCs as the unit of cluster randomisation. To check
for similarity between participants within clusters, which
could adversely affect the trial’s ability to detect a differ-
ence between trial arms, the intracluster correlation
coefﬁcient (ICC)30 is reported for cost and outcome
variables. Participants were English-speaking ﬁrst-time
mothers who had recently given birth and attended par-
ticipating MCHCs. Baseline participant characteristics
were compared between trial arms using two-sample
t-tests and Pearson’s χ2 tests.
Intervention
The training programme for nurses at intervention
MCHCs comprised online and face-to-face components,
with nurses who worked at more than one centre
excluded to avoid cross-contamination between the
intervention and control groups. Participants at inter-
vention centres received WWWT-informed care during
MCH visits, and both parents were invited to attend an
extra 6-hour FTP group session on a Saturday, during
which the WWWT intervention was delivered, and
received printed materials to take home. Participants at
control MCHCs were provided usual MCH care, and
were offered no extra FTP group sessions.
Resource use and cost
Participants were sent a card at baseline on which to
record the use of health and other services during the
follow-up period for themselves or their baby (specifying
the service type and cost including OOP cost), and
these data were collected at follow-up. This card and the
service use questions asked at follow-up were developed
speciﬁcally for the trial. Resource unit costs were identi-
ﬁed from the Medicare Beneﬁts Schedule (MBS),31
National Efﬁcient Price (NEP) determination weights
for hospital episodes,32 the standard hourly rate of MCH
service provision,18 participants’ OOP costs and market
rates (for further detail, see online supplementary
material). All unit costs were in 2013–2014 Australian
dollars ($A).
The estimated cost of the intervention per participant
was based on the costs of developing the intervention,
training MCH nurses in the intervention and delivery of
the WWWT session as an additional FTP group session.
It was assumed that WWWT-informed MCHC care would
entail the same cost per visit as standard care, with any
difference in the number of visits or phone calls cap-
tured in participants’ service use history. The cost of
delivering the intervention to participants was based on
the hourly rate of MCH services. In the base case, it was
assumed that MCH nurses would need retraining after
3 years, and that six families would attend each FTP
group session on average.
Outcomes
For CEA, the outcome was 30-day prevalence of depres-
sion, anxiety and adjustment disorders according to the
criteria of the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV).33 For CUA,
the outcome was QALYs, with HRQoL measured using
the three-level version of the EQ-5D (EQ-5D-3L), and
calculated using Australian weights derived using the
time trade off approach.34 QALYs were calculated as a
linear change in HRQoL over time between baseline
and follow-up.
The EQ-5D is a multiattribute utility instrument35 that
assesses HRQoL over ﬁve domains of health: mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression. A score of one reﬂects full health, and zero,
death. It is the most frequently used HRQoL measure
when estimating QALYs,36 and has been used in the
postnatal context.37–40 Petrou et al41 found, among
women at 6 months postpartum, an average EQ-5D
score of 0.861 (95% CI 0.844 to 0.877), and a statistically
signiﬁcant correlation with PND risk.
Analysis
Costs and outcomes were adjusted using regression mod-
elling to account for relevant sociodemographic, prog-
nostic and clinical characteristics, including those
differing between groups, with the effect of the interven-
tion captured by the inclusion of the trial arm as a vari-
able. All regression models included baseline measures
of the participant’s psychological well-being and psychi-
atric history and a measure of the baby’s crying behav-
iour, to account for differences in baseline risks for
postnatal mental health problems, plus the baby’s age at
baseline to account for timing of data points. In add-
ition, the cost model included factors that might inﬂu-
ence utilisation of health and other services: level of
education, health care card status (a health care card
provides access to concessions on pharmaceuticals and
medical services for low-income earners and those
receiving government beneﬁts) and relative socio-
economic disadvantage of the participant’s area of resi-
dence.42 The outcome models included baseline
EQ-5D-3L score to account for baseline HRQoL, plus
other factors which might inﬂuence quality of life: per-
ceived quality of the intimate partner relationship and
level of support, and a measure of adverse life events
(for further details regarding measures used in the
study, see ref. 29). Analyses were performed in STATA
V.13 using a generalised linear regression model (GLM)
for cost, to allow for the non-normal distribution of costs
without requiring transformation of the cost variable,43 a
linear regression model for QALYs and a logit model for
the binary clinical outcome (presence or absence of
depression, anxiety and adjustment disorders). The
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speciﬁcations of the GLM model for costs were informed
by a modiﬁed Parks test, resulting in a log link and
gamma family,43 while the distribution of QALYs ﬁtted
with the assumption of normality in the linear regression
model. Since these regression models included different
explanatory variables than those included in the clinical
evaluation,29 the results may differ slightly. Cluster-robust
SEs were used to account for randomisation at the level
of the MCHC, rather than the individual.
The main analysis was conducted on participants for
whom complete data were collected, and repeated with
imputation of missing data. Characteristics of those with
missing data were compared with the complete cases
using two-sample t-tests and Pearson’s χ2 tests. Missing
values for cost, outcomes and two characteristics (adverse
life events and levels of support) used in regression ana-
lyses were imputed using the ‘mi impute chained’
command in STATA with V.30 imputations. Predictive
mean matching was used for continuous variables, with
logistic regression for binary and ordered logistic regres-
sion for ordinal variables, using an imputation model that
included characteristics associated with missingness of
data as well as the variables in the analytic model.
The incremental cost-effectiveness ratio (ICER) com-
pares the control and intervention groups by dividing
the difference in cost by the difference in outcome
(each calculated using average marginal effects from the
relevant regression model). Uncertainty surrounding
the ICER was estimated using non-parametric bootstrap-
ping44 (resampling with replacement from the original
data to produce replicates of the sample), resampling
clusters rather than individuals. The distribution of the
resulting 2000 estimates of the ICER on the cost-
effectiveness plane45 depicts the joint uncertainty sur-
rounding costs and outcomes. Estimates in the lower
right quadrant of a cost-effectiveness plane suggest that
the intervention is more effective and less costly, while
estimates in the upper right quadrant suggest it is more
effective but costlier. Estimates in this quadrant require
further analysis to determine if the decision-maker
would be willing to allocate the extra expenditure for
the extra beneﬁt. The cost-effectiveness acceptability
curve46 is used for that purpose, to display the probabil-
ity that the intervention is cost-effective at a given soci-
etal WTP threshold (ie, the proportion of the
bootstrapped estimates that fall below the threshold)
over a range of thresholds.
Scenario analyses
Cost per QALY was re-estimated under alternative scen-
arios to explore the results’ sensitivity to particular
assumptions or parameters. (1) Using only variables col-
lected at baseline to adjust cost and outcomes; that is,
excluding support and adverse life event variables from
the regression models, which were collected at follow-up.
(2) Assuming that MCH nurses would require retraining
in the intervention after 1 year (instead of 3 years as in
the base case). (3) Assuming that the average number of
families per session would be 5 or 7 (rather than 6 as in
the base case). (4) Limiting the cost analysis to the
health sector, the early childhood sector or combined
public sector without participant OOP costs. (5) To test
the sensitivity of the results to variation in costs and out-
comes, for a worst-case scenario, incremental costs were
assumed to be at the upper end of the 95% CI and
incremental outcomes at the lower end for each individ-
ual, while for a best-case scenario, the reverse assump-
tions were applied. (6) To test the sensitivity of the
results to the speciﬁcations of the models, linear regres-
sion was used for all three models.
EQ-5D-3L scores across clinical states
We also explored the usefulness of the EQ-5D-3L for dis-
criminating between clinical states in postnatal mental
health, using the Mann-Whitney U test to investigate
whether EQ-5D-3L scores differed signiﬁcantly between
participants with and without major depressive disorder,
and those with and without symptoms of anxiety or
depression. The Mann-Whitney U test47 was used because
the EQ-5D-3L scores were (as expected) non-normally
distributed, with a skew to the upper limit of 1, and so
would not meet the assumptions for a two-sample t-test.
RESULTS
Baseline
Cluster randomisation resulted in the allocation of 196
participants across 24 MCHCs to the control arm and
204 participants across 24 MCHCs to the intervention
arm (although one MCHC in the control arm did not
recruit any participants). Overall, 21 participants
(10.7%) from the control arm and 20 (9.8%) from the
intervention arm did not complete the full follow-up
interview, leaving 175 in the control arm and 184 in the
intervention arm for complete case analysis. Baseline
interviews took place between May 2013 and April 2014,
and follow-up interviews between September 2013 and
August 2014.
Participants’ baseline characteristics, outlined in
table 1, were similar between groups except that the
intervention group had higher depression (p=0.045)
and anxiety (p=0.004) scores and more participants with
a history of eating or dieting disorders (p=0.039), while
the control group reported a higher number of hours
that the baby cried or fussed per day (p=0.048). These
variables were included in the regression models for costs
and outcomes, along with other relevant characteristics.
The pattern of missing data was monotone, since close
to 100% of data were non-missing at the initial interview,
and most data missing at follow-up involved the entire
interview. Data were not missing completely at random,
as those with missing data were more likely to be born
overseas, speak a language other than English, hold a
health care card had lower levels of education and gave
lower self-reported health ratings, but were no different
in psychiatric history. These characteristics were included
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in the model for multiple imputation of missing data in
scenario analysis.
The mean baseline EQ-5D-3L utility score was 0.859,
with no statistically signiﬁcant difference between the
groups. However, in answering the anxiety/depression
EQ-5D-3L domain question, more of the intervention
group (20%) reported moderate anxiety or depression
than the control group (13%) (p=0.054).
Outcomes
At follow-up, the unadjusted 30-day prevalence of
DSM-IV diagnoses of depression, anxiety and adjustment
disorders was 8.57% in the control group, and 8.70% in
the intervention group (p=0.967, ICC <0.001).
EQ-5D-3L scores at follow-up were also similar
between the control (0.890) and intervention groups
(0.889) (p=0.980), with 23% of the control group and
20% of the intervention group reporting moderate
anxiety/depression, and 2% of the intervention group
reporting extreme anxiety/depression (none in the
control group) (p=0.107).
Individual QALYs were calculated by dividing the
mean of the two EQ-5D-3L scores for each person by
their duration of follow-up, which varied from 78 to
288 days depending on the baby’s age at recruitment
(1.1–15.6 weeks) but was similar between groups
(p=0.779). The mean QALY accumulated for the
control group was 0.371 and for the intervention group
was 0.372 (p=0.883, ICC 0.034).
After regression modelling to account for relevant
sociodemographic, prognostic and clinical character-
istics, the differences between groups were still not statis-
tically signiﬁcant; using complete case analysis, the
intervention group had a 1.77 percentage-point lower
Table 1 Baseline participant characteristics
Characteristic at baseline Control group Intervention group p Value test of difference*
N 175 184
Mean (SD) Mean (SD) t-test
Mean age, years 31.3 (5.12) 31.0 (5.10) 0.563
EQ-5D score 0.859 (0.14) 0.858 (0.15) 0.910
Socioeconomic index for areas1 1009.57 (30.12) 1014.43 (40.08) 0.197
Depression score2 3.46 (3.27) 4.20 (3.61) 0.045
Anxiety score2 2.77 (2.97) 3.85 (3.90) 0.004
Number of hours baby fusses or cries per 24 hours 3.30 (2.52) 2.83 (1.92) 0.048
N (%) N (%) Pearson χ2 test
Country of birth 0.794
Australia 138 (78.86) 143 (77.72)
Language spoken at home 0.310
English 145 (82.86) 159 (86.41)
English+other 21 (12.00) 21 (11.41)
Other 9 (5.14) 4 (2.17)
Level of education 0.738
University degree 115 (65.71) 114 (61.96)
TAFE or college certificate or diploma 33 (18.86) 37 (20.11)
Up to completion of high school 27 (15.43) 33 (17.93)
Marital status 0.083
Married or de facto 165 (94.29) 180 (97.83)
Single or not living with partner 10 (5.71) 4 (2.17)
Health care card holder 26 (14.86) 18 (9.78) 0.143
Private health insurance 124 (70.86) 113 (61.41) 0.059
Self-rated health 0.706
Excellent 62 (35.43) 64 (34.78)
Very good 89 (50.86) 89 (48.37)
Good 24 (13.71) 31 (16.85)
History of…
Any psychiatric disorder 37 (21.14) 52 (28.26) 0.118
Depression 24 (13.71) 37 (20.11) 0.107
Anxiety 25 (14.29) 30 (16.30) 0.596
Post-traumatic stress disorder 6 (3.43) 4 (2.17) 0.470
Eating or dieting disorder 2 (1.14) 9 (4.89) 0.039
Alcohol or drug dependence 1 (0.57) 4 (2.17) 0.195
Physical or sexual abuse 10 (5.71) 18 (9.78) 0.151
1 42 2 PHQ-958 3 PHQ GAD-7.59
*Bold indicates statistically significant at 5% level of significance.
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prevalence of depression, anxiety and adjustment disor-
ders (p=0.497) and 0.007 higher QALYs accrued
(p=0.417) than the control group. From the analysis
using multiple imputation of missing data, the interven-
tion group had 0.33 percentage-point lower prevalence
(p=0.643) and 0.006 higher QALYs (p=0.544).
Costs
The estimated intervention cost per participant was
$A118.16 in the base case. This included MCH nurse
time to deliver the intervention (based on an average of
6 families attending each WWWT 6-hour session) and to
complete the 3-hour self-directed training and the day
and a half of face-to-face training in the intervention. It
also included development costs to account for previous
research conducted in developing WWWT. Average per-
participant intervention costs were calculated as if the
intervention were to be delivered state-wide, rather than
using the numbers in attendance during the trial, as the
intervention was delivered as routine at intervention
MCH centres. The intervention MCH centres delivered
WWWT-informed care to all women at the centres, as it
was randomised at the centre level, and more women
attended WWWT sessions than the number who
enrolled in the trial, so the approach had to vary from
the usual per-participant trial cost estimation. For the
trial, 33 MCH nurses were trained in the WWWT
approach, and a total of 44 seminars were delivered by
these nurses to an average of 4 families per session.
Almost half (46%) of women in the intervention arm of
the trial attended a seminar (further details of the
implementation of the intervention in the trial are avail-
able in Fisher et al.29)
Table 2 outlines the service use accrued during the
period of follow-up. There were no statistically signiﬁcant
differences in service use between the intervention and
control groups.
As shown in table 3, costs of health and other services
were $A158.37 higher per participant (p=0.580, ICC
0.002) in the intervention than control group, mostly
arising from statistically insigniﬁcant higher health
service costs in the intervention group. Inclusive of inter-
vention costs, the difference was $A276.53, and although
this difference was not statistically signiﬁcant, the inter-
vention cost component was an addition to usual care
costs.
Table 2 Service use during the follow-up period
Control (N=175)
Intervention
(N=184)
Two-sided
t-test
Service type No. Mean No. Mean p Value
MCH services
MCH visit 793 4.5 800 4.4 0.581
MCH home visit 74 0.4 89 0.5 0.612
MCH telephone line 192 1.1 232 1.3 0.581
First-time parents’ group 845 4.8 924 5.0 0.525
Mental health
Psychologist, psychiatrist or counsellor 105 0.6 108 0.6 0.966
Psychiatric mother–baby unit admission 0 0.0 2 0.0 0.167
Web therapy session 16 0.1 106 0.6 0.289
Antidepressant, anxiolytic or sedative 11 0.1 20 0.1 0.161
Primary care
GP 516 2.9 623 3.4 0.213
Clinic nurse 27 0.2 42 0.2 0.324
Nurse-on-call (telephone helpline) 59 0.3 70 0.4 0.599
Medical
Obstetrician 67 0.4 88 0.5 0.232
Paediatrician 117 0.7 115 0.6 0.764
Other specialist 12 0.1 12 0.1 0.924
Allied health (physiotherapist, dietician or social worker) 197 1.1 268 1.5 0.316
Complementary healthcare 266 1.5 254 1.4 0.693
Hospital-related
Outpatients 85 0.5 105 0.6 0.597
Emergency department visit 47 0.3 54 0.3 0.725
Total days hospital admission 71 0.4 35 0.3 0.320
Early parenting services
Residential early parenting centre 6 0.0 6 0.0 0.940
Early parenting centre day stay 16 0.1 17 0.1 0.976
Breastfeeding telephone helpline 85 0.5 90 0.5 0.979
Lactation consultant, mothercraft nurse, support group or
other parenting service
145 0.8 157 0.9 0.922
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After adjustment using regression modelling and
inclusive of costs relating to the intervention, with com-
plete case analysis, the intervention group had $A268.69
additional costs (p=0.335) per participant; with imput-
ation of missing data, the estimated additional cost was
$A249.75 (p=0.311).
Cost-effectiveness
While neither costs nor outcomes demonstrated statistic-
ally signiﬁcant differences between groups, a point esti-
mate of the ICER can still be calculated based on the
trial results, and can be informative as the best available
estimate of cost-effectiveness,48 albeit with a high degree
of uncertainty surrounding the result. Using complete
case analysis, the estimated cost per percentage-point
reduction in 30-day prevalence of depression, anxiety
and adjustment disorders was $A152 (95% CI −16 453
to 16 756). The estimated cost per QALY was $A36 451
(95% CI −1554 006 to 1 626 908). As shown in ﬁgure 1,
the bootstrapped estimates of incremental costs and
QALYs were in all four quadrants, reﬂecting the
uncertainty both costs and effectiveness. The majority
(69%) fell in the northeast quadrant, suggesting that the
intervention might be costlier and more effective. The
bootstrapped estimates for the clinical effectiveness
outcome showed a similar pattern (available as online
supplementary ﬁgure S1).
At a threshold of $A55 000 per QALY, there is a 55%
probability that the intervention is cost-effective.
(Cost-effectiveness acceptability curve is available as
online supplementary ﬁgure S2.) At a threshold of
$A100 000 per QALY, the probability only rises by a
small increment (to 67%) due to the uncertainty sur-
rounding the effectiveness of the intervention.
Using the analysis that imputed missing values
(intention-to-treat analysis), the estimated cost per
percentage-point reduction in 30-day prevalence of
depression, anxiety and adjustment disorders was
$A747 and the estimated cost per QALY was $A44 830.
These higher ICERs were driven by smaller differences
in outcomes in the imputed data set. Using this
approach, at the $55 000 per QALY threshold, there
Table 3 Unadjusted costs by sector ($A, 2014)
Cost sector
Control
Mean (SE)
Intervention
Mean (SE)
Difference
Mean (SE) Two-sided t-test
Public sector 1353.66 (188.18) 1428.60 (190.19) 74.93 (267.79) p=0.780
Health 776.84 (176.06) 847.95 (156.50) 71.11 (235.02) p=0.762
Early childhood 429.40 (22.02) 438.80 (15.76) 9.41 (26.87) p=0.727
Human services 147.43 (50.43) 141.85 (61.41) -5.58 (79.90) p=0.944
Participant out-of-pocket 343.77 (31.28) 377.29 (42.07) 33.52 (52.88) p=0.527
Total (non-intervention) 1647.52 (192.67) 1805.89 (209.49) 158.37 (285.50) p=0.580
Intervention cost – 118.16 118.16
Total cost 1647.52 (192.67) 1924.05 (209.49) 276.53 (285.50) p=0.333
Figure 1 Cost-effectiveness plane—cost per quality-adjusted life year.
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was a 53% probability that the intervention is
cost-effective.
Scenario analyses
The estimated ICERs under each scenario shown in
table 4 demonstrate the potential impact of different
methodological approaches or perspectives. Since most
of the difference in non-intervention costs arose from
the use of health rather than other services, limiting the
perspective to the health sector gave a higher ICER than
the base case. Limiting it to costs attributable to the
early childhood sector (which is responsible for funding
MCH services in Victoria) shows a much more favour-
able ICER. Participant OOP costs contributed to the
cost difference, so that a public sector perspective
(which excludes these) gave a lower ICER. The use of a
GLM model for costs and logit model for the clinical
outcome, chosen because of their superior theoretical
basis, produced a higher ICER than when linear regres-
sion models were used.
EQ-5D-3L scores across clinical states
There was a gradient of EQ-5D-3L scores over increasing
severity of depression and anxiety symptoms, as shown
in ﬁgure 2. The mean EQ-5D-3L scores were found to
differ signiﬁcantly between those with (0.682) and
without (0.878) major depressive disorder (p<0.001),
and those with (0.806) and without (0.917) symptoms of
depression or anxiety (p<0.001).
DISCUSSION
This study found that WWWT may be associated with
higher costs and a small improvement in HRQoL and
reduced prevalence of PND, anxiety and adjustment dis-
orders when compared with usual MCH care, although
Table 4 Scenario analyses: cost-effectiveness ($A, 2014)
Incremental cost-effectiveness ratio (ICER)
Scenario
Cost per
quality-adjusted
life year (CUA)
Cost per %-point reduction
in 30-day prevalence of
depression, anxiety and
adjustment disorders (CEA)
Probability of
cost-effectiveness at
threshold of $A55 000
per QALY (%)
Base case $36 451.04 $151.67 55
With multiple imputation of missing data $44 830.07 $746.68 53
Only baseline variables in regression models $34 332.92 $159.10 57
Assuming MCH nurse training lasts 1 year $39 041.07 $162.44 54
Number of participants per WWWT session=5 $39 214.87 $163.17 54
Number of participants per WWWT session=7 $34 473.05 $143.44 56
Health sector costs only $50 359.59 $209.54 47
Early childhood sector costs only $18 466.31 $76.84 68
Public sector costs only $29 919.03 $124.49 58
Incremental costs at upper end of 95% CI,
incremental outcomes at lower end of 95% CI
$65 362.84 $1881.41 36
Incremental costs at lower end of 95% CI,
incremental outcomes at upper end of 95% CI
$19 245.54 $25.91 67
Linear models for costs and outcomes $19 706.80 $97.28 62
Figure 2 The mean EQ-5D-3L
scores by severity of PHQ
depression and anxiety scores.
*PHQ, Patient Health
Questionnaire.
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these differences were not statistically signiﬁcant. We
focus on the ﬁndings regarding cost per QALY gained,
since there is no generally accepted level of WTP for
one unit of improvement in the clinical outcome, and
there is more acceptance of cost per QALY evidence by
decision-makers.
The point estimate of the ICER, $A36 451 per QALY
gained, was lower than the unofﬁcial threshold of
$A55 000,23 as were all but one of the higher ICERs esti-
mated under differing assumptions in the scenario ana-
lyses outlined in table 4. There was considerable
uncertainty surrounding this result, with only a 55%
probability that the intervention was cost-effective at a
threshold of $A55 000 per QALY. The large differences
in ICER dependent on which public sector costs were
included are of particular importance since MCH
services in Victoria are funded with early childhood
services, while the intervention might be considered to
ﬁt better within a health sector perspective.
Other CEA of preventive interventions in postnatal
mental health have evaluated targeted rather than uni-
versal preventive interventions and/or have used differ-
ing clinical end points as the measure of effectiveness,
leading to difﬁculties in comparing results. For example,
the PoNDER trial,49 which used QALYs as an outcome
measure but targeted women at risk of PND, found no
statistically signiﬁcant difference in costs or QALYs and a
probability of cost-effectiveness of around 80% at a
threshold of £20 000–30 000 per QALY gained. A
Canadian study,10 which investigated a programme of
peer support for high-risk women in terms of cost per
case of PND averted (rather than cost per QALY), found
the point estimate of the ICER to be $CAD10 009 per
case averted. In a UK study9 focusing on counselling
and support for women at risk of PND, no statistically
signiﬁcant differences were found in costs and out-
comes, with a probability of cost-effectiveness of 71% at
a threshold of £1000 per month of PND averted.
While this study did not demonstrate savings in
unadjusted health service utilisation associated with the
intervention, the intervention group had statistically sig-
niﬁcantly worse baseline depression and anxiety scores
but not (as might have been expected) statistically sig-
niﬁcantly higher health service costs. This ﬁnding in
relation to the use of residential early parenting centres
may be of particular interest to the early childhood
sector, since these are high-cost services and have
similar risk factors to those addressed by the
intervention.50
The data were not missing completely at random, sug-
gesting that intention-to-treat analysis with imputation of
missing values may be appropriate. However, it is not
possible to tell from the observed data whether the
pattern of missingness also depends on the outcome
variable, and under some patterns of missingness
(involving correlation with covariates), complete case
analysis may be unbiased. Therefore, complete case and
intention-to-treat analyses are presented.51
The correlation we found between EQ-5D-3L score
and postnatal mental health supports previous ﬁndings
that the EQ-5D-3L is able to discriminate between clinic-
ally signiﬁcant mental health states.52 53 We found statis-
tically signiﬁcant differences in EQ-5D-3L scores based
not only on diagnosis of major depressive disorder, but
also based on symptoms of depression or anxiety (a
lower clinical threshold).
Limitations and possibilities for further research
Sample size calculations were based on the clinical
effect rather than cost-effectiveness analysis,54 55 which
may have contributed to uncertainty surrounding the
results. The cluster-randomised nature of the trial and
small but non-negligible ICC for QALYs may also have
reduced the ability to detect an effect of the interven-
tion on QALYs in this trial.30
No extrapolation beyond the 6-month time horizon of
the trial was conducted, since there were no statistically
signiﬁcant differences in this period. However, signiﬁ-
cant differences between the intervention and control
groups may have emerged with a longer follow-up
period.
This evaluation focused on costs of public sector ser-
vices and OOP costs for mothers and infants. Since post-
natal mental health problems in couples tend to
co-occur,56 and since the intervention explicitly included
participants’ partners and addressed the partner rela-
tionship, future research into WWWT could include part-
ners’ costs and outcomes, including partners’
productivity. In the postnatal context, mothers’ work-
force participation may be low even in the absence of
mental health problems,57 which may limit the relevance
of productivity in terms of mothers’ employment.
The cost analysis depended on participants’ recall of
service use. To minimise recall error, participants were
asked to record services used during the follow-up
period and were prompted by interviewers to refer to
this record and to report use of a wide range of services.
In this study, WWWT was evaluated as additional to
standard FTP group sessions. However, there is a range
of standard sessions available, from which MCHCs
choose. If WWWT were incorporated into this range, the
cost would be absorbed into usual FTP group costs but
other content would be displaced. Future research could
estimate the cost-effectiveness of WWWT in head-to-head
comparison with other FTP group sessions rather than
as an additional session.
Research into the cost-effectiveness of WWWT using
alternative delivery mechanisms (such as online), and
WTP (societal and/or decision-makers’) for prevention
of postnatal mental health problems could also be valu-
able to decision-makers.
CONCLUSIONS
This economic evaluation conducted alongside a cluster-
randomised trial found no statistically signiﬁcant
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difference in either costs or effectiveness, with a point
estimate of cost-effectiveness that suggests WWWT might
be a cost-effective intervention for the prevention of
postnatal mental health problems in ﬁrst-time mothers.
Given the dearth of cost-effective preventive interven-
tions in this ﬁeld and the clinical, social and economic
incentives to prevent postnatal mental health problems,
further research is warranted to reduce the uncertainty
surrounding the results.
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